GlassScriptPhysician profile
Nichole Racquel Moos
NPI 1841674850
$7,650.30
in general payments reported to CMS, 2019-2025
14 companies · $986 in 2025
The $986 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,317 · 2020: $550 · 2021: $554 · 2022: $2,440 · 2023: $844 · 2024: $960 · 2025: $986.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,604 · Entertainment: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,604.41 |
| Entertainment | $184.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $3,771.43 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $994.90 | 2019-2025 | Tryptyr, Precision7, Total30 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $841.87 | 2019-2021 | |
| Coopervision INC. | $453.06 | 2020-2025 | Myday Contact Lens, Misight Contact Lens |
| Tarsus Pharmaceuticals, INC. | $397.15 | 2024 | Xdemvy |
| Bausch & Lomb Americas INC. | $383.16 | 2022-2025 | Infuse, Alden Scleral Zenlens, Biotrue One Day |
| Optos, INC. | $254.73 | 2019-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Abb Con-Cise Optical Group LLC | $169.74 | 2019-2021 | |
| Oyster Point Pharma, INC. | $122.74 | 2023 | Tyrvaya |
| Allergan, INC. | $90.74 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $62.22 | 2021-2025 | |
| Genentech USA, INC. | $54.11 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $28.93 | 2023 | Meibomian Gland Evaluator |
| Carl Zeiss Meditec USA, INC. | $25.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nichole Moos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.